top of page

Strategic MOU with INFINITT Healthcare

February 5, 2026


CrystarVision have signed a Memorandum of Understanding (MOU) with INFINITT Healthcare, a globally recognized medical imaging and PACS company from Korea.


INFINITT Healthcare has extensive experience in medical imaging infrastructure and PACS-based clinical workflows across domestic and international healthcare institutions.


Through this collaboration, Crystar Vision aims to integrate Reticare AI, its AI-based ophthalmic diagnostic solution, with hospital imaging and PACS workflows.


This partnership represents an important step toward bringing ophthalmology AI into real-world clinical infrastructure and making AI-powered eye care more accessible in everyday clinical practice.


We look forward to working with INFINITT Healthcare to advance practical, safe, and clinically meaningful AI solutions for ophthalmology.

크리스타비전 로고

Representative

Su Jeong Song

Business Registration Number

835-87-03137

Address

Head Office: 9F, Ilshin Building, 38 Mapo-daero, Mapo-gu, Seoul, Republic of Korea


Branch Office: B1F, 265 Baekjegobun-ro, Songpa-gu, Seoul, Republic of Korea

Contact

(+82) 02-2001-1963

Reticare is a device that assists with ophthalmic diagnosis and does not replace the direct diagnosis or treatment by a medical professional.
All results must ultimately be reviewed and confirmed by a healthcare provider.
Users are advised to use the information provided by Reticare only as a reference or supplementary material.  We prioritize the protection of patient data and privacy.
All data is processed securely in compliance with relevant privacy regulations.
All content, including images and software on this website, is the property of Crystar Vision and is protected by copyright law. Unauthorized reproduction, distribution, or use is prohibited and may result in legal action without prior consent.

© CrystarVision(크리스타비전) All rights reserved.

  • X
  • Instagram
bottom of page